Linezolid:: pharmacokinetic characteristics and clinical studies

被引：37

作者：

Bouza, E ^{[1
]}

Muñoz, P ^{[1
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid 28007, Spain

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2001年 / 7卷

关键词：

D O I：

10.1046/j.1469-0691.2001.00061.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Linezolid is an oxazolidinone indicated in the treatment of nosocomial and community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections and vancomycin-resistant Enterococcus infections. The drug is also approved for use in complicated skin infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus, concurrent bacteremia associated with vancomycin-resistant Enterococcus faecium and concurrent bacteremia associated with community-acquired pneumonia caused by penicillin-susceptible Streptococcus pneumoniae.

引用

页码：75 / 82

页数：8

共 42 条

[31] PAWSEY SD, 1966, 1 EUR C CHEM GLASG 1
[32] Linezolid - A review of its use in the management of serious Gram-positive infections
Perry, CM
Jarvis, B
[J]. DRUGS, 2001, 61 (04) : 525 - 551
[33] *PHARM UPJ CO, 2000, LIN PRESCR INF
[34] *PHARM UPJ CO, 1998, LIN INV BROCH
[35] *PHARM UPJ CO, 1999, ZYV DIN GEN REV
[36] ROOT JD, 2000, 40 INT C ANT AG CHEM, P448
[37] Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study
Rubinstein, E
Cammarata, SK
Oliphant, TH
Wunderink, RG
[J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 402 - 412
[38] Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
Stevens, DL
Smith, LG
Bruss, JB
McConnell-Martin, MA
Duvall, SE
Todd, WM
Hafkin, B
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3408 - 3413
[39] Trissel L A, 2000, J Am Pharm Assoc (Wash), V40, P515
[40] WILKS NE, 1999, 39 INT C ANT AG CHEM, P40

← 1 2 3 4 5 →